(Q52930339)

9 May 2018

title

Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. (English)

1 reference

9 May 2018

postmenopausal hormone-replacement therapy

main subject

1 reference

10

1 reference

9 May 2018

author name string

Brian L Strom

1

1 reference

9 May 2018

Rita Schinnar

2

1 reference

9 May 2018

Anita L Weber

3

1 reference

9 May 2018

Greta Bunin

4

1 reference

9 May 2018

Jesse A Berlin

5

1 reference

9 May 2018

Mona Baumgarten

6

1 reference

9 May 2018

Angela DeMichele

7

1 reference

9 May 2018

Stephen C Rubin

8

1 reference

9 May 2018

Michelle Berlin

9

1 reference

9 May 2018

Timothy R Rebbeck

11

1 reference

9 May 2018

language of work or name

English

0 references

publication date

22 September 2006

1 reference

9 May 2018

American Journal of Epidemiology

published in

1 reference

9 May 2018

volume

164

1 reference

9 May 2018

issue

8

1 reference

9 May 2018

page(s)

775-786

1 reference

9 May 2018

Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women

cites work

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Quality of life and menopause: the role of estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure-a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Changing patterns in endometrial adenocarcinoma: a study of 291 consecutive cases at a large private hospital, 1960-1973.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Increasing Incidence of Endometrial Cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Cancer of the corpus uteri: increasing incidence in the United States, 1970--1975.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

The rising frequency of hysterectomy: its effect on uterine cancer rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Recent patterns of hormone replacement therapy use in a large managed care organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Practical aspects of sharing controls between case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Simulation study of confounder-selection strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

The impact of confounder selection criteria on effect estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Alternative analytic methods for case-control studies of estrogens and endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

Agreement between interview information and physician records on history of menopausal estrogen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ316

21 January 2018

Identifiers

DOI

10.1093/AJE/KWJ316

1 reference

9 May 2018

PubMed ID

16997897

1 reference

9 May 2018